This purpose of this study is to determine if the administration of ezetimibe and simvastatin together is more effective than simvastatin alone in lowering LDL-C levels to a goal of \<100 mg/dL in patients at risk for Heart Disease.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
616
LDL-C measurement (target goal = <100 mg/dL)
Time frame: 27 Weeks
Well tolerated in patients
Time frame: 27 Weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.